NO984979L - Biologisk materiale som er fritt for virale og molekylµre patogener samt fremgangsmÕte ved fremstilling derav - Google Patents

Biologisk materiale som er fritt for virale og molekylµre patogener samt fremgangsmÕte ved fremstilling derav

Info

Publication number
NO984979L
NO984979L NO984979A NO984979A NO984979L NO 984979 L NO984979 L NO 984979L NO 984979 A NO984979 A NO 984979A NO 984979 A NO984979 A NO 984979A NO 984979 L NO984979 L NO 984979L
Authority
NO
Norway
Prior art keywords
biological material
viral
free
pathogens
preparation
Prior art date
Application number
NO984979A
Other languages
English (en)
Other versions
NO984979D0 (no
Inventor
Noel Barrett
Johann Eibl
Friedrich Dorner
Lsler Gerhard P
Thomas Hommerle
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of NO984979D0 publication Critical patent/NO984979D0/no
Publication of NO984979L publication Critical patent/NO984979L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04Heat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Det er beskrevet et biologisk materiale som er fritt for bestemte patogener, spesielt virale patogener, samt en fremgangsmåte for fjerning av virale og molekylære patogener fra et bio- logisk materiale, hvorved et biologisk materi- ale blandes med minst en ligand eller reseptor som reagerer med en reseptor eller ligand av det bestemte patogen, hvorved det dannes et ligand/reseptor-kompleks, og separasjon av li- gand/reseptor-komplekset ved en fremgangsmåte som muliggjør den delvise eller fullstendige separasjon av det komplekserte patogen fra det biologiske materiale, og anvendelsen av frem- gangsmåten ved fremstilling av et biologisk materiale.
NO984979A 1996-04-30 1998-10-26 Biologisk materiale som er fritt for virale og molekylµre patogener samt fremgangsmÕte ved fremstilling derav NO984979L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0078096A AT403477B (de) 1996-04-30 1996-04-30 Biologisches material frei von viralen und molekularen pathogenen und verfahren zur herstellung
PCT/AT1997/000075 WO1997040861A1 (de) 1996-04-30 1997-04-23 Biologisches material frei von viralen und molekularen pathogenen und verfahren zur herstellung

Publications (2)

Publication Number Publication Date
NO984979D0 NO984979D0 (no) 1998-10-26
NO984979L true NO984979L (no) 1998-12-23

Family

ID=3499569

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984979A NO984979L (no) 1996-04-30 1998-10-26 Biologisk materiale som er fritt for virale og molekylµre patogener samt fremgangsmÕte ved fremstilling derav

Country Status (8)

Country Link
EP (1) EP0900089A1 (no)
JP (1) JP2000510107A (no)
AT (1) AT403477B (no)
AU (1) AU731048B2 (no)
CA (1) CA2253300A1 (no)
IL (1) IL126810A0 (no)
NO (1) NO984979L (no)
WO (1) WO1997040861A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6221614B1 (en) 1997-02-21 2001-04-24 The Regents Of The University Of California Removal of prions from blood, plasma and other liquids
US6617119B2 (en) 1997-02-21 2003-09-09 The Regents Of The University Of California Assay for specific strains of multiple disease related conformations of a protein
US6720355B2 (en) 1997-02-21 2004-04-13 The Regents Of The University Of California Sodium dodecyl sulfate compositions for inactivating prions
US6620629B1 (en) 1997-02-21 2003-09-16 The Regents Of The University Of California Method for detecting prions
AU726999B2 (en) * 1997-06-13 2000-11-30 Baxter Aktiengesellschaft Process for reducing the concentration of viral and molecular pathogens in a biological material
DE19752898A1 (de) * 1997-11-28 1999-08-05 Centeon Pharma Gmbh Verfahren zum Nachweis hoher Vierenkonzentrationen im Blutplasma und/oder Blutserum mittels der Polymerasekettenreaktion
US5977324A (en) * 1998-02-20 1999-11-02 The Regents Of The University Of California Process for concentrating protein with disease-related conformation
ATE318176T1 (de) * 1998-08-31 2006-03-15 Julian L Ambrus Verfahren zur entfernung von hiv und anderen viren aus blut
CA2392797A1 (en) * 1999-12-02 2001-06-07 V.I. Technologies, Inc. Method of identifying a ligand for a target molecule
AU2002242086A1 (en) * 2001-02-02 2002-08-19 Chemocentryx, Inc. Chemomagnetic retrieval of cmv and cmv infected cells
CN101124315A (zh) 2003-01-17 2008-02-13 伊势龙医学股份有限公司 利用凝集素亲和性血液透析去除血液中病毒的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896218A (en) * 1972-07-13 1975-07-22 Research Corp Radiommunoassay determining the hepatitis associated antigen content of blood
ZA838856B (en) * 1982-12-02 1984-07-25 Usv Pharma Corp Hepatitis b and non-a-non-b-safe biological products
JPS63243032A (ja) * 1987-03-27 1988-10-07 Green Cross Corp:The トロンビンの加熱処理方法
WO1990015992A1 (en) * 1989-06-15 1990-12-27 Smith William I Jr Method and apparatus for inactivating infectious agents in and resisting coagulation of biological fluids
EP0443724B1 (en) * 1990-02-20 1999-03-17 Baxter International Inc. Viral-safe purified human thrombin
EP0447984A1 (en) * 1990-03-20 1991-09-25 Abbott Laboratories Hyperimmune globulin against hepatitis C virus and method for making same
DE4125625C2 (de) * 1991-08-02 1999-12-02 Octapharma Ag Glarus Verfahren zur Herstellung von virusinaktivierten Immunglobulinlösungen
DE4142908C2 (de) * 1991-12-24 1994-02-10 Octapharma Ag Glarus Verfahren zur Herstellung eines virusinaktivierten Prothrombinkomplex-Konzentrats (PPSB)
EP0679405A1 (de) * 1994-04-25 1995-11-02 Rotkreuzstiftung Zentrallaboratorium Blutspendedienst Srk Verfahren zur Abtrennung von Viren aus Proteinlösungen
AT406019B (de) * 1995-05-08 2000-01-25 Immuno Ag Verfahren zur herstellung eines arzneimittels enthaltend ein oder mehrere plasmaderivate

Also Published As

Publication number Publication date
EP0900089A1 (de) 1999-03-10
WO1997040861A1 (de) 1997-11-06
AU731048B2 (en) 2001-03-22
IL126810A0 (en) 1999-08-17
CA2253300A1 (en) 1997-11-06
NO984979D0 (no) 1998-10-26
AT403477B (de) 1998-02-25
JP2000510107A (ja) 2000-08-08
AU2561297A (en) 1997-11-19
ATA78096A (de) 1997-07-15

Similar Documents

Publication Publication Date Title
NO984979L (no) Biologisk materiale som er fritt for virale og molekylµre patogener samt fremgangsmÕte ved fremstilling derav
DE69022896D1 (de) Verfahren und System, um Poststücke vorzubereiten.
NO176221C (no) FremgangsmÕte for °kning av argongjenvinning fra en blanding, f.eks. luft
DE58902183D1 (de) Verfahren zur reinigung von rohem, gasfoermigem chlorwasserstoff.
DK0891420T3 (da) Fremgangsmåde til replikation af influenzavirus i cellekultur samt de ved fremgangsmåden opnåelige influenzavirus
EP1149841A3 (de) Verfahren zur Herstellung von 6B,7B;15B,16B-dimethylene-5B-hydroxy-3-oxo-17alpha-androstane-21,17-carbolactone
EP0630280A4 (en) METHOD AND DEVICE FOR REMOVING DNA, VIRUSES AND ENDOTOXINS.
DE69012636D1 (de) Verfahren zur Trennung von Makromolekülen.
IL67235A (en) 3-(1-substituted-4-piperidyl)-1,2-benzisoxazoles,a process for the preparation thereof,and pharmaceutical compositions comprising the same
EP0755440A4 (en) NOVEL MUT VIRUSES, ANTIVIRAL COMPOUNDS, AND NOVEL VACCINE PRODUCTION METHODS
DE69009318D1 (de) Vorrichtung zur Extraktion von Antigenen.
NL184958B (nl) Werkwijze ter bereiding van een polysilan en werkwijze voor de bereiding van al dan niet gevormd, keramisch siliciumcarbide bevattend materiaal daaruit.
DE69009614D1 (de) Verfahren zur Herstellung von (S)-gamma-Hydroxymethyl-alpha,beta-Butenolid.
DK0585439T3 (da) Fremgangsmåde til rensning af spildgasser, især fra vakuumpyrolyseanlæg.
ATE421339T1 (de) Vereinfachte methode zur entfernung von freiem protein während der herstellung von protein- polysaccharid-konjugaten und impfstoffen unter verwendung von medien mit limitierter durchlässigkeit
AU747417C (en) Filtration method for separating viruses
DE60038677D1 (de) Verfahren zum nachweis von proteinen, die miteinander interagieren
DK0402199T3 (da) Fremgangsmåde til fremstilling af elektrosvejsbar muffe, anordning til udøvelse af fremgangsmåden samt muffer fremstillet ved fremgangsmåden
DE3774579D1 (de) Vorrichtung und verfahren zum leeren von verpackungen, insbesondere von saecken.
DE68908162D1 (de) Verfahren zur herstellung von keramischen produkten, insbesondere von keramischen federn.
DE3778503D1 (de) Vorrichtung zum herstellen von verbundwerkstoffen.
EP0836652A4 (en) METHODS, KITS AND COMPOSITIONS FOR DIAGNOSING PAPILLOMA VIRUS INFECTION
ATE194602T1 (de) Verfahren zur herstellung von 1,4,7,10- tetraazacyclododecan und dessen derivaten
IL102615A0 (en) Immunoassay kits and methods for the detection of antibodies
DE3365284D1 (en) Process for the sequence analysis by mass spectroscopy of a, if necessary modified oligoribonucleotide or oligodesoxyribonucleotide